210 related articles for article (PubMed ID: 15067092)
1. B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice.
Silveira PA; Dombrowsky J; Johnson E; Chapman HD; Nemazee D; Serreze DV
J Immunol; 2004 Apr; 172(8):5086-94. PubMed ID: 15067092
[TBL] [Abstract][Full Text] [Related]
2. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
[TBL] [Abstract][Full Text] [Related]
3. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors.
Silveira PA; Johnson E; Chapman HD; Bui T; Tisch RM; Serreze DV
Eur J Immunol; 2002 Dec; 32(12):3657-66. PubMed ID: 12516557
[TBL] [Abstract][Full Text] [Related]
4. Genes within the Idd5 and Idd9/11 diabetes susceptibility loci affect the pathogenic activity of B cells in nonobese diabetic mice.
Silveira PA; Chapman HD; Stolp J; Johnson E; Cox SL; Hunter K; Wicker LS; Serreze DV
J Immunol; 2006 Nov; 177(10):7033-41. PubMed ID: 17082619
[TBL] [Abstract][Full Text] [Related]
5. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
[TBL] [Abstract][Full Text] [Related]
7. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.
Yamanouchi J; Verdaguer J; Han B; Amrani A; Serra P; Santamaria P
J Immunol; 2003 Dec; 171(12):6900-9. PubMed ID: 14662897
[TBL] [Abstract][Full Text] [Related]
8. Uncoupling of anergy from developmental arrest in anti-insulin B cells supports the development of autoimmune diabetes.
Acevedo-Suárez CA; Hulbert C; Woodward EJ; Thomas JW
J Immunol; 2005 Jan; 174(2):827-33. PubMed ID: 15634904
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
Hussain S; Delovitch TL
J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
[TBL] [Abstract][Full Text] [Related]
10. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
[TBL] [Abstract][Full Text] [Related]
11. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
Kanagawa O; Shimizu J; Vaupel BA
J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
[TBL] [Abstract][Full Text] [Related]
12. Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice.
Noorchashm H; Moore DJ; Noto LE; Noorchashm N; Reed AJ; Reed AL; Song HK; Mozaffari R; Jevnikar AM; Barker CF; Naji A
J Immunol; 2000 Oct; 165(8):4685-96. PubMed ID: 11035112
[TBL] [Abstract][Full Text] [Related]
13. Through regulation of TCR expression levels, an Idd7 region gene(s) interactively contributes to the impaired thymic deletion of autoreactive diabetogenic CD8+ T cells in nonobese diabetic mice.
Serreze DV; Choisy-Rossi CM; Grier AE; Holl TM; Chapman HD; Gahagan JR; Osborne MA; Zhang W; King BL; Brown A; Roopenian D; Marron MP
J Immunol; 2008 Mar; 180(5):3250-9. PubMed ID: 18292549
[TBL] [Abstract][Full Text] [Related]
14. Tolerant anti-insulin B cells are effective APCs.
Kendall PL; Case JB; Sullivan AM; Holderness JS; Wells KS; Liu E; Thomas JW
J Immunol; 2013 Mar; 190(6):2519-26. PubMed ID: 23396943
[TBL] [Abstract][Full Text] [Related]
15. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.
Falcone M; Lee J; Patstone G; Yeung B; Sarvetnick N
J Immunol; 1998 Aug; 161(3):1163-8. PubMed ID: 9686575
[TBL] [Abstract][Full Text] [Related]
16. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance.
Hippen KL; Schram BR; Tze LE; Pape KA; Jenkins MK; Behrens TW
J Immunol; 2005 Jul; 175(2):909-16. PubMed ID: 16002689
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of autoimmune diabetes in nonobese diabetic mice by transgenic restoration of H2-E MHC class II expression: additive, but unequal, involvement of multiple APC subtypes.
Johnson EA; Silveira P; Chapman HD; Leiter EH; Serreze DV
J Immunol; 2001 Aug; 167(4):2404-10. PubMed ID: 11490031
[TBL] [Abstract][Full Text] [Related]
18. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice.
Serreze DV; Gaskins HR; Leiter EH
J Immunol; 1993 Mar; 150(6):2534-43. PubMed ID: 8450229
[TBL] [Abstract][Full Text] [Related]
19. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
Kanagawa O; Militech A; Vaupel BA
J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
[TBL] [Abstract][Full Text] [Related]
20. Signals from a self-antigen induce positive selection in early B cell ontogeny but are tolerogenic in adults.
Ferry H; Crockford TL; Leung JC; Cornall RJ
J Immunol; 2006 Jun; 176(12):7402-11. PubMed ID: 16751385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
